Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Does a clinical trial warrant an economic analysis?
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
Economic analysis of the clinical uses of the colony-stimulating factors.
The ASCO experience with evidence-based clinical practice guidelines.
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.
Re: Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use.
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.
Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.
Granulocyte Colony-Stimulating Factor
Receptors, Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Wiser use of dose-dense adjuvant therapy in breast cancer.
A way forward on the medically appropriate use of white cell growth factors.
Comparison of pegfilgrastim prescribing practice to national guidelines at a university hospital outpatient oncology clinic.
Colony Stimulating Factor